New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Research highlights industry and regulatory perspectives on improving diversity in clinical trials

Research highlights industry and regulatory perspectives on improving diversity in clinical trials

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainClinical Cancer Researchpublished an article today outlining steps clinical trial sponsors can take to improve di
Oncology February 18,2024
Research highlights industry and regulatory perspectives on improving diversity in clinical trials

Research highlights industry and regulatory perspectives on improving diversity in clinical trials

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainClinical Cancer Researchpublished an article today outlining steps clinical trial sponsors can take to improve di
Oncology February 18,2024
Researcher discusses how lung macrophages evolve during metastatic growth of lung colonies in a mouse model of melanoma

Researcher discusses how lung macrophages evolve during metastatic growth of lung colonies in a mouse model of melanoma

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainA new editorial paper titled "A macrophage is a macrophage is a macrophage—in metastasis" has been published inOncotarget.In thi
Oncology February 18,2024
Researcher discusses how lung macrophages evolve during metastatic growth of lung colonies in a mouse model of melanoma

Researcher discusses how lung macrophages evolve during metastatic growth of lung colonies in a mouse model of melanoma

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainA new editorial paper titled "A macrophage is a macrophage is a macrophage—in metastasis" has been published inOncotarget.In thi
Oncology February 18,2024
'Dead zone' within tumor promotes cancer spread, helped by a protein secreted by cancer cells

'Dead zone' within tumor promotes cancer spread, helped by a protein secreted by cancer cells

by Diana Mapes, Fred Hutchinson Cancer CenterFred Hutch's Ami Yamamoto, foreground, at work in the lab of Dr. Kevin Cheung (seen in background). Yamamoto's investigation of the necrotic core o
Oncology February 18,2024
'Dead zone' within tumor promotes cancer spread, helped by a protein secreted by cancer cells

'Dead zone' within tumor promotes cancer spread, helped by a protein secreted by cancer cells

by Diana Mapes, Fred Hutchinson Cancer CenterFred Hutch's Ami Yamamoto, foreground, at work in the lab of Dr. Kevin Cheung (seen in background). Yamamoto's investigation of the necrotic core o
Oncology February 18,2024
Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

by Brandon Chase,Massachusetts General HospitalA molecule called MHC-II (seen here in green) disguises metastatic breast cancer cells (red), allowing them to invade the lymph nodes and take root
Oncology February 18,2024
Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

by Brandon Chase,Massachusetts General HospitalA molecule called MHC-II (seen here in green) disguises metastatic breast cancer cells (red), allowing them to invade the lymph nodes and take root
Oncology February 18,2024
Lethal cancer cells buddy up to survive

Lethal cancer cells buddy up to survive

by University of California, IrvineConsistent Metabolic Features in a Second PDA Clonal Cell Model and Media Metabolite Profiling.A. Dose response curves of oligomycin treated KPC clones 28
Oncology February 18,2024
Lethal cancer cells buddy up to survive

Lethal cancer cells buddy up to survive

by University of California, IrvineConsistent Metabolic Features in a Second PDA Clonal Cell Model and Media Metabolite Profiling.A. Dose response curves of oligomycin treated KPC clones 28
Oncology February 18,2024
Phase 1 study: New medicine extends terminally-ill cancer patients' lives

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague
Oncology February 18,2024
Phase 1 study: New medicine extends terminally-ill cancer patients' lives

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague
Oncology February 18,2024
Researchers identify innovative strategy with potential to enhance bowel cancer treatment

Researchers identify innovative strategy with potential to enhance bowel cancer treatment

by University of GalwayGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112475Researchers at University of Galway studying cell interactions in bowel cancer h
Oncology February 18,2024
Researchers identify innovative strategy with potential to enhance bowel cancer treatment

Researchers identify innovative strategy with potential to enhance bowel cancer treatment

by University of GalwayGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112475Researchers at University of Galway studying cell interactions in bowel cancer h
Oncology February 18,2024
Study: Women more likely to postpone cancer screening than men during COVID-19 pandemic

Study: Women more likely to postpone cancer screening than men during COVID-19 pandemic

by eLifeCredit: Unsplash/CC0 Public DomainResearchers have revealed differences in cancer screening uptake during the pandemic according to people's sex, age, education, race and ethnicity.Th
Oncology February 18,2024
Study: Women more likely to postpone cancer screening than men during COVID-19 pandemic

Study: Women more likely to postpone cancer screening than men during COVID-19 pandemic

by eLifeCredit: Unsplash/CC0 Public DomainResearchers have revealed differences in cancer screening uptake during the pandemic according to people's sex, age, education, race and ethnicity.Th
Oncology February 18,2024
Study: Diet, exercise improve outcomes of chemotherapy for women with breast cancer

Study: Diet, exercise improve outcomes of chemotherapy for women with breast cancer

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA new Yale Cancer Center study finds a targeted diet and exercise intervention could improve outcomes for women undergoing
Oncology February 18,2024
Study: Diet, exercise improve outcomes of chemotherapy for women with breast cancer

Study: Diet, exercise improve outcomes of chemotherapy for women with breast cancer

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA new Yale Cancer Center study finds a targeted diet and exercise intervention could improve outcomes for women undergoing
Oncology February 18,2024
Research unveils genetic characteristics and improved prognosis of triple-negative apocrine carcinoma

Research unveils genetic characteristics and improved prognosis of triple-negative apocrine carcinoma

by JooHyeon Heo,Ulsan National Institute of Science and TechnologySomatic Point Mutations in TNAC and LK-TNBC. The top 16 significantly mutated genes as determined by the dNdScv algorithm (p &lt
Oncology February 18,2024
Research unveils genetic characteristics and improved prognosis of triple-negative apocrine carcinoma

Research unveils genetic characteristics and improved prognosis of triple-negative apocrine carcinoma

by JooHyeon Heo,Ulsan National Institute of Science and TechnologySomatic Point Mutations in TNAC and LK-TNBC. The top 16 significantly mutated genes as determined by the dNdScv algorithm (p &lt
Oncology February 18,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com